Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America

ABSTRACT: Antibodies are an essential component of the adaptative immune response and hold long-term memory of the immunological experiences throughout life. Antibody defects represent approximately half of the well-known primary immunodeficiencies requiring immunoglobulin replacement therapy. In this article, the authors review the current indications and therapeutic protocols in the Latin American environment. Immunoglobulin replacement therapy has been a safe procedure that induces dramatic positive changes in the clinical outcome of patients who carry antibody defects.

• Autores: Condino Neto, Antonio; Costa Carvalho, B. T.; Grumach, A. S.; King, A.; Bezrodnik, L.; Oleastro, M.; Leiva, L.; Porras, O.; Espinosa Rosales, F. J.; Franco Restrepo, José Luis; Sorensen, R. U.
• Tipo de recurso: Article of investigation
• Fecha de publicación: 2014
• Institución: Universidad de Antioquia
• Repositorio: Repositorio UdeA
• Idioma: eng
• OAI Identifier: oai:bibliotecadigital.udea.edu.co:10495/21292
• Acceso en línea: http://hdl.handle.net/10495/21292
• Palabra clave: Inmunoglobulinas; Immunoglobulins; Enfermedades de Inmunodeficiencia Primaria; Primary Immunodeficiency Diseases; América Latina; Latin America; Immunoglobulin replacement therapy; Subcutaneous immunoglobulin
• Rights: openAccess
• License: http://creativecommons.org/licenses/by-nc-nd/2.5/co/